Why shares in Newcrest Mining are down 9% in five days

Skittish gold investors are still uncertain about Newcrest Mining's prospects despite focus on cost reductions.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Australia's largest gold producer, Newcrest Mining (ASX: NCM), continued their relentless slide last week, dropping over 9% despite a small increase in the price for gold.

Newcrest shares opened the week at $8.49 and closed at $7.69 on Friday. This brings Newcrest's drop over the last month to 22% and almost 78% over the last two years. It's a huge amount given the price for gold has fallen just 27% over the same period.

This suggests that either Newcrest Mining was heavily overvalued to begin with, or that the lack of investor confidence extends beyond the gold price to the company itself. The answer could be a combination of the two, with new fears emerging about the company's cash position being raised by Credit Suisse.

The financial service company believes Newcrest is bleeding cash and still needs to cut costs more aggressively and sell assets to stem the losses according to The Wall Street Journal. Credit Suisse reportedly notes that Newcrest will be $210 million below its full FY14 assumptions if current 2014 production guidance is achieved and the current gold spot prices remain constant.

Newcrest has made big efforts to cut costs over the last six months and last month announced that more jobs would be cut from the company's Telfer gold mine in Western Australia as it scales back production and trims costs.

Despite the reduction effort, a comparison of 'all-in sustaining cost' per ounce for the most recent September quarter shows Newcrest's costs are higher than some other listed Australian gold producers including Alacer Gold (ASX: AQG) and Northern Star Resources (ASX: NST), while just below the costs of Silver Lake Resources (ASX: SLR).

Foolish takeaway

If Newcrest is forced to sell assets in an effort to increase cash flows, investors could be concerned the company will struggle to attract a reasonable price, particularly because the value of mines generally corresponds to the price of gold. After being slugged for more than $5 billion in write-downs earlier this year, it is not a situation any Newcrest investor will be happy about.

Motley Fool contributor Regan Pearson does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »